Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease
<p>Abstract</p> <p>Background</p> <p>Dimebon is a retired non-selective antihistamine drug currently being investigated as a therapeutic agent for the treatment of Alzheimer's disease (AD). Results from several completed clinical trials are mixed and contradictory. Proper interpretations of these cl...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2011-01-01
|
| Serie: | Molecular Neurodegeneration |
| Accesso online: | http://www.molecularneurodegeneration.com/content/6/1/7 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|